Nanologica is a Swedish nanotechnology company, world-leading in the development of nanoporous silica particles for purification by chromatography. A proprietary production method enables the company to create supreme products by precisely controlling the shape, size, porosity, and surface properties of silica particles. Nanologica provides products of high-quality silica used in the purification of peptide drugs such as insulin and GLP-1 analogues. These products can contribute to lower costs and increase productivity for pharmaceutical manufacturers, which can increase the availability of cost-effective medicines and give more people around the world access to vital treatment for diabetes and obesity. Nanologica is headquartered in Södertälje and Nanologica's share (NICA) is listed on Nasdaq Stockholm Main Market. For further information, please visit www.nanologica.com.
View Top Employees from Nanologica ABWebsite | https://nanologica.com/ |
Revenue | $5 million |
Employees | 25 (25 on RocketReach) |
Founded | 2004 |
Address | 20 g Forskargatan, Soedertaelje, Stockholm, SE |
Phone | +46 8 410 749 49 |
Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
Industry | Drug Delivery, Biotechnology Research, Manufacturing General, Nanotechnology, Chromatography, Manufacturing, Science and Engineering |
Web Rank | 18 Million |
Keywords | Nanologica |
Competitors | DelSiTech Ltd, Kriya Materials B.V., Liquidia Corporation, Minerva Biotechnologies, Nano Magnetics Ltd |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Nanologica AB employee's phone or email?
The Nanologica AB annual revenue was $5 million in 2024.
Gary Pitcairn is the Chief Scientific Officer of Nanologica AB.
25 people are employed at Nanologica AB.
Nanologica AB is based in Soedertaelje, Stockholm.
The NAICS codes for Nanologica AB are [32, 325, 3254, 32541].
The SIC codes for Nanologica AB are [283, 28].